Milagritos D Tapia

Summary

Affiliation: University of Maryland
Country: USA

Publications

  1. doi request reprint Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa
    Milagritos D Tapia
    Centre pour le Développement des Vaccins, Bamako, Mali
    Vaccine 30:A79-85. 2012
  2. ncbi request reprint A serosurvey to identify the window of vulnerability to wild-type measles among infants in rural Mali
    Milagritos D Tapia
    Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA
    Am J Trop Med Hyg 73:26-31. 2005
  3. ncbi request reprint Measurement of tetanus antitoxin in oral fluid: a tool to conduct serosurveys
    Milagritos D Tapia
    Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA
    Pediatr Infect Dis J 25:819-25. 2006
  4. pmc Naturally acquired and conjugate vaccine-induced antibody to Haemophilus influenzae type b (Hib) polysaccharide in Malian children: serological assessment of the Hib immunization program in Mali
    Julia Hütter
    Center for Vaccine Development and the Departments of Pediatrics and Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    Am J Trop Med Hyg 86:1026-31. 2012
  5. pmc Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial
    Milagritos D Tapia
    Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD, USA
    Lancet Infect Dis 16:1026-35. 2016
  6. pmc Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-bli
    Milagritos D Tapia
    Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD, USA Centre pour le Développement des Vaccins du Mali, Bamako, Mali, West Africa
    Lancet Infect Dis 16:31-42. 2016
  7. pmc Antibody Persistence 1-5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12-23 Months of Age
    Milagritos D Tapia
    Department of Pediatrics, Center for Vaccine Development, University of Maryland School of Medicine, Baltimore
    Clin Infect Dis 61:S514-20. 2015
  8. ncbi request reprint Haemophilus influenzae Type B conjugate vaccine introduction in Mali: impact on disease burden and serologic correlate of protection
    Samba O Sow
    Centre pour le Développement des Vaccins, Mali CVD Mali, Bamako, Mali
    Am J Trop Med Hyg 80:1033-8. 2009
  9. pmc A Phase 3, Double-Blind, Randomized, Active Controlled Study to Evaluate the Safety of MenAfriVac in Healthy Malians
    Milagritos D Tapia
    Department of Pediatrics, Center for Vaccine Development, University of Maryland School of Medicine, Baltimore
    Clin Infect Dis 61:S507-13. 2015
  10. pmc Streptococcal pharyngitis in schoolchildren in Bamako, Mali
    Milagritos D Tapia
    From the Division of Infectious Disease and Tropical Pediatrics, Department of Pediatrics and Division of Geographic Medicine, Department of Medicine, Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland Centre pour le Développement des Vaccins Mali, Bamako, Mali Department of Pediatrics, University of Virginia, Charlottesville, Virginia and University of Tennessee Health Science Center and Veterans Affairs Medical Center Research Service, Memphis, Tennessee
    Pediatr Infect Dis J 34:463-8. 2015

Detail Information

Publications11

  1. doi request reprint Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa
    Milagritos D Tapia
    Centre pour le Développement des Vaccins, Bamako, Mali
    Vaccine 30:A79-85. 2012
    ..PRV provides protection against severe-RVGE caused by diverse rotavirus genotypes, including those not contained in the vaccine...
  2. ncbi request reprint A serosurvey to identify the window of vulnerability to wild-type measles among infants in rural Mali
    Milagritos D Tapia
    Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA
    Am J Trop Med Hyg 73:26-31. 2005
    ..The early onset of the window of vulnerability in Kangaba infants likely reflects the changing ecology of measles in Africa. Ways to protect these vulnerable infants against measles must be devised...
  3. ncbi request reprint Measurement of tetanus antitoxin in oral fluid: a tool to conduct serosurveys
    Milagritos D Tapia
    Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA
    Pediatr Infect Dis J 25:819-25. 2006
    ..Measurement of IgG tetanus antitoxin in oral fluid was investigated as a practical and noninvasive alternative to and correlate of serum antibodies...
  4. pmc Naturally acquired and conjugate vaccine-induced antibody to Haemophilus influenzae type b (Hib) polysaccharide in Malian children: serological assessment of the Hib immunization program in Mali
    Julia Hütter
    Center for Vaccine Development and the Departments of Pediatrics and Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    Am J Trop Med Hyg 86:1026-31. 2012
    ..0 μg/mL; a level that impedes Hib upper respiratory carriage, and may thereby diminish the Hib transmission to the unimmunized susceptible population (i.e., providing indirect protection)...
  5. pmc Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial
    Milagritos D Tapia
    Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD, USA
    Lancet Infect Dis 16:1026-35. 2016
    ..We aimed to assess the safety, immunogenicity, and efficacy of maternal immunisation with trivalent inactivated influenza vaccine for protection of infants against a first episode of laboratory-confirmed influenza...
  6. pmc Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-bli
    Milagritos D Tapia
    Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD, USA Centre pour le Développement des Vaccins du Mali, Bamako, Mali, West Africa
    Lancet Infect Dis 16:31-42. 2016
    ....
  7. pmc Antibody Persistence 1-5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12-23 Months of Age
    Milagritos D Tapia
    Department of Pediatrics, Center for Vaccine Development, University of Maryland School of Medicine, Baltimore
    Clin Infect Dis 61:S514-20. 2015
    ..Antibody persistence in healthy African toddlers was investigated...
  8. ncbi request reprint Haemophilus influenzae Type B conjugate vaccine introduction in Mali: impact on disease burden and serologic correlate of protection
    Samba O Sow
    Centre pour le Développement des Vaccins, Mali CVD Mali, Bamako, Mali
    Am J Trop Med Hyg 80:1033-8. 2009
    ..0 microg/mL. Introduction of Hib vaccine led to rises in anti-PRP seroprevalence, significant reductions in Hib disease, and all-cause hospitalizations, whereas S. pneumoniae disease remained unchanged...
  9. pmc A Phase 3, Double-Blind, Randomized, Active Controlled Study to Evaluate the Safety of MenAfriVac in Healthy Malians
    Milagritos D Tapia
    Department of Pediatrics, Center for Vaccine Development, University of Maryland School of Medicine, Baltimore
    Clin Infect Dis 61:S507-13. 2015
    ..Documentation of the safety specifications of the PsA-TT vaccine was warranted, with sufficient exposure to detect potential rare vaccine-related adverse reactions...
  10. pmc Streptococcal pharyngitis in schoolchildren in Bamako, Mali
    Milagritos D Tapia
    From the Division of Infectious Disease and Tropical Pediatrics, Department of Pediatrics and Division of Geographic Medicine, Department of Medicine, Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland Centre pour le Développement des Vaccins Mali, Bamako, Mali Department of Pediatrics, University of Virginia, Charlottesville, Virginia and University of Tennessee Health Science Center and Veterans Affairs Medical Center Research Service, Memphis, Tennessee
    Pediatr Infect Dis J 34:463-8. 2015
    ..We sought to identify guidelines for empiric treatment of pharyngitis in low-resource settings. To inform the design of GAS vaccines, we determined the emm types associated with pharyngitis among African schoolchildren...
  11. ncbi request reprint Burden of invasive disease caused by Haemophilus influenzae type b in Bamako, Mali: impetus for routine infant immunization with conjugate vaccine
    Samba O Sow
    Centre pour le Développement des Vaccins, Mali CVD Mali
    Pediatr Infect Dis J 24:533-7. 2005
    ..Population-based, bacteriologically confirmed disease burden data aid decision makers in African countries pondering whether to introduce Haemophilus influenzae type b (Hib) immunization for infants...